Evidence of self-synergism in the antinociceptive effect of tramadol in rats
Conference Paper
Overview
Research
Identity
Additional Document Info
View All
Overview
abstract
Tramadol is an atypical opioid with a complex mechanism of action including the synergistic interaction between the parent drug and an active metabolite. However, the local action of the parent drug is poorly documented. This study was designed to evaluate the site-site interaction of the antinociception produced by tramadol given by two different routes. The effects of individual and fixed-ratio combinations of locally (subcutaneous) and systemically (intraperitoneal) dosed tramadol were evaluated using the formalin test in rats. Isobolographic analysis was employed to identify the synergy produced by combinations. In the second phase of the formalin test, tramadol was active not only by the systemic (ED50 7.15 ± 0.46 mg/kg i.p.) but also by the local route (ED50 134.6 ± 25.1 μg/paw). The isobolographic analysis evidenced a self-synergism in the antinociceptive effect between the two routes of administration since the experimental ED50 (30.8 ± 0.1 dose units) of the combination was significantly lower than the theoretical ED50 (70.9 ± 12.6 dose units). The mechanism underlying this self-synergism appears to be partially opioid since naloxone reversed the potentiation. The observed site-site interaction in the antinociceptive action of tramadol provides insights for alternatives in the management of pain. This study was partially supported by CONACyT, Grant 38940-M.
